Eris Lifesciences Limited has informed the Exchange regarding Allotment of 6761 Shares.
ERIS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Eris Lifesciences has allotted 6,761 equity shares on August 30, 2025, following the exercise of stock options by employees under the ESOP-2021 Scheme. The shares were allotted at different prices based on grant year: 616 shares at Rs. 557.24 (2022 grant), 2,178 shares at Rs. 510.32 (2023 grant), and 3,967 shares at Rs. 728.16 (2024 grant). As a result, the company's paid-up share capital has increased marginally from Rs. 13.62 crore to Rs. 13.62 crore (in absolute terms, from 13,62,06,793 to 13,62,13,554 shares of Re. 1 each).
This is a routine ESOP allotment with a negligible impact on share capital (about 0.05% increase in share count) and no material effect on existing shareholders or stock price.